Related references
Note: Only part of the references are listed.Association Between Payments by Pharmaceutical Manufacturers and Prescribing Behavior in Rheumatology
Ali Duarte-Garcia et al.
MAYO CLINIC PROCEEDINGS (2022)
Pharmaceutical payments to Japanese certified hematologists: a retrospective analysis of personal payments from pharmaceutical companies between 2016 and 2019
Eiji Kusumi et al.
BLOOD CANCER JOURNAL (2022)
Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-Year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019
Anju Murayama et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)
Industry Payments to Practicing US Rheumatologists, 2014-2019
Michael S. Putman et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Ophthalmology Patient Perceptions of Open Payments Information
Gregory E. Stein et al.
JAMA OPHTHALMOLOGY (2018)
Industry Payments to Cardiologists An Analysis of the Open Payments Program From 2014 to 2016
Amarnath Annapureddy et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2018)
Public Awareness of and Contact With Physicians Who Receive Industry Payments: A National Survey
Genevieve Pham-Kanter et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2017)
Open Payments goes live with pharma to doctor fee data: first analysis
Duncan Jarvies et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)